(Q40199686)

18 September 2017

Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles (English)

1 reference

18 September 2017

Shi H

1

1 reference

18 September 2017

Zeng C

2

1 reference

18 September 2017

Ricome A

3

1 reference

18 September 2017

Hannon KM

4

1 reference

18 September 2017

Grant AL

5

1 reference

18 September 2017

Gerrard DE

6

1 reference

18 September 2017

6 December 2006

1 reference

American Journal of Physiology - Cell Physiology

18 September 2017

1 reference

18 September 2017

292

1 reference

18 September 2017

5

1 reference

18 September 2017

C1681-9

1 reference

Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases

18 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Microgravity-induced transformations of myosin isoforms and contractile properties of skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Cellular and molecular regulation of muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Signalling pathways that mediate skeletal muscle hypertrophy and atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Inhibition of MAP/ERK kinase prevents IGF-I-induced hypertrophy in rat muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

MAPK-regulated transcription: a continuously variable gene switch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Muscle fiber pattern is independent of cell lineage in postnatal rodent development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Three myosin heavy chain isoforms in type 2 skeletal muscle fibres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

beta 2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Nicotinic acid adenine dinucleotide phosphate: a new intracellular second messenger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

Transactivation joins multiple tracks to the ERK/MAPK cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00466.2006

10.1152/AJPCELL.00466.2006

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference